2011-2021季节十年间流感疫苗真实世界有效性——疫苗不匹配的影响
该多中心前瞻性队列研究纳入2011至2021年韩国10个医疗中心的5322名≥65岁流感样病例成人,采用检测阴性设计评估季节性流感疫苗在10个季节中对疫苗与流行株抗原匹配的有效性。结果显示仅3个季节抗原匹配度>70%,疫苗有效性随季节显著变化,匹配季节为28.8%,不匹配季节为-12.0%,疫苗接种使流感相关住院减少13.6%。
要点
- 仅3个季节(33.3%)疫苗与流行株抗原匹配度>70%。
- 疫苗有效性随季节变化,从2011/12季的-46.9%到2016/17季的47.7%。
- 匹配季节疫苗有效性28.8%,不匹配季节-12.0%,疫苗接种使流感相关住院减少13.6%。
核心结论
- 研究期间疫苗不匹配频繁出现,导致不匹配季节疫苗有效性极低。
- 接种流感疫苗可降低流感相关住院风险。
研究设计与样本
- 多中心前瞻性队列研究,2011至2021年在韩国10个医疗中心纳入流感样病例患者。
- 采用检测阴性设计,评估季节性流感疫苗对疫苗与流行株抗原匹配的有效性。
- 共纳入5322名年龄≥65岁的成人。
- 通过问卷调查和电子病历收集人口学和临床数据。
主要发现
- 九个季节中仅三个季节(33.3%)疫苗与流行株抗原匹配度>70%。
- 流感疫苗有效性随季节显著变化,范围从2011/12季的-46.9%(95%CI:-127.6至5.2)到2016/17季的47.7%(95%CI:22.6至64.7)。
- 疫苗有效性因疫苗株与流行株是否匹配而显著不同:匹配季节为28.8%(95%CI:8.8至44.8),不匹配季节为-12.0%(95%CI:-30.0至3.7)。
- 整个研究期间,接种疫苗使流感相关住院减少13.6%(95%CI:0.7至24.8)。
- 亚组分析中,疫苗对流感相关住院的有效性在A/H3N2优势季节为48.4%(95%CI:29.6至62.2),在A/H1N1优势季节为53.8%(95%CI:-73.4至87.7)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Influenza imposes a significant healthcare burden in Korea, leading the government to initiate a national immunization program. Previous studies on vaccine effectiveness (VE) were limited to single-season estimation in Korea. METHODS: This multicenter prospective cohort study enrolled patients with influenza-like illnesses at 10 medical centers in Korea from 2011 to 2021. The demographic and clinical data were collected from questionnaire surveys and electronic medical records. Using a test-negative design, we aimed to investigate the effectiveness of a seasonal influenza vaccine for antigenic matching of the vaccine and circulating viral strains over 10 seasons. RESULTS: Overall, 5322 adults aged ≥65 years were enrolled. Only three (33.3 %) of nine seasons showed >70 % antigenic match between vaccine and circulating strains. Influenza VE was significantly variable by season, ranging from -46.9 % (95 %confidence interval [CI]: -127.6-5.2) in the 2011/12 season to 47.7 % (95 %CI: 22.6-64.7) in the 2016/17 season. A significant difference was observed in the VE depending on whether the vaccine strains matched with epidemic strains: 28.8 % (95 %CI: 8.8-44.8) in matched seasons versus -12.0 % (95 %CI: -30.0-3.7) in mismatched seasons. Across the study period, influenza-related hospitalizations were reduced by 13.6 % (95 %CI: 0.7-24.8) with vaccination. In a subgroup analysis, the VE against influenza-related hospitalization was 48.4 % (95 %CI 29.6-62.2) in A/H3N2 dominant seasons and 53.8 % (95 %CI: -73.4-87.7) in A/H1N1 dominant seasons, respectively. CONCLUSION: Influenza vaccine mismatch was frequent over the study period, leading to negligibly low VE in mismatched seasons. Influenza vaccination reduces the risk of influenza-related hospitalizations.
引用
- Choi YJ, Song JY, Wie SH, et al. Real-world effectiveness of influenza vaccine over a decade during the 2011-2021 seasons-Implications of vaccine mismatch. Vaccine. 2024. PMID: 39362009. doi:10.1016/j.vaccine.2024.126381
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。